Inhibition of the MET kinase activity by JNJ38877605 or inhibition of the biological activity of HGF by SRI31215, a novel small molecule inhibitor of pro-HGF activation, restored sensitivity of HGF-producing colon cancer cells to EGFR inhibition by blocking autocrine MET activation. This evidence concerns the gene HGF and malignant colon neoplasm.